American International Group, Inc. Nautilus Biotechnology, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.41 - $3.18 $515 - $680	-214 Reduced 0.85%	24,880 $73,000
Q4 2023 Feb 13, 2024	SELL	$2.34 - $3.39 $236 - $342	-101 Reduced 0.4%	25,094 $75,000
Q3 2023 Nov 13, 2023	BUY	$2.87 - $3.94 $2,571 - $3,530	896 Added 3.69%	25,195 $79,000
Q2 2023 Aug 04, 2023	BUY	$2.21 - $4.52 $2,857 - $5,844	1,293 Added 5.62%	24,299 $94,000
Q1 2023 May 12, 2023	BUY	$1.67 - $2.77 $766 - $1,271	459 Added 2.04%	23,006 $63,000
Q4 2022 Feb 10, 2023	SELL	$1.55 - $2.47 $127 - $202	-82 Reduced 0.36%	22,547 $40,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.13 $627 - $1,001	320 Added 1.43%	22,629 $48,000
Q2 2022 Aug 12, 2022	BUY	$2.64 - $4.84 $58,895 - $107,975	22,309 New	22,309 $60,000

64.3M

1.9K

100

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $297M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.